UK markets close in 4 hours 12 minutes

Perspective Therapeutics, Inc. (CATX)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
1.7600-0.0800 (-4.35%)
At close: 04:00PM EDT
1.8000 +0.04 (+2.27%)
Pre-market: 07:01AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
0
0
10,795
10,053
9,680
Cost of revenue
-
-
6,179
4,932
4,556
Gross profit
-
-
4,616
5,121
5,124
Operating expenses
Research development
21,311
21,311
2,582
1,427
1,126
Selling general and administrative
21,064
21,064
9,425
7,131
7,547
Total operating expenses
40,941
40,941
12,007
8,558
8,600
Operating income or loss
-40,941
-40,941
-7,391
-3,437
-3,476
Interest expense
84
84
-
-
-
Total other income/expenses net
-15
-15
-
-9
-
Income before tax
-40,106
-40,106
-7,272
-3,387
-3,446
Income tax expense
-2,651
-2,651
-
-
-
Income from continuing operations
-37,455
-37,455
-7,272
-3,387
-3,446
Net income
-46,508
-46,508
-7,272
-3,387
-3,446
Net income available to common shareholders
-46,508
-46,508
-7,272
-3,390
-3,457
Basic EPS
-0.04
-0.17
-0.05
-0.03
-0.05
Diluted EPS
-0.04
-0.17
-0.05
-0.03
-0.05
Basic average shares
136,823
267,643
141,987
103,841
67,601
Diluted average shares
136,823
267,643
141,987
103,841
67,601